INCB annual report highlights the spread of illicit synthetic drugs, obstacles in access to controlled medicines, and the effectiveness of affiliated initiatives and programmes.
Health Poverty Action proposes restructuring illegal trades to prioritise public health, equity, and sustainability rather than reproducing harmful market practices.
Transform models the spending and revenue outcomes for three post-prohibition market scenarios, noting potential annual net benefits to the Treasury of up to £1.5 billion.
IHRNGO and ECPM notes a significant increase in drug-related executions, disproportionately impacting marginalised communities, and calls on the UN and wider international community to act.
IDPC provides background information on the scheduling of the coca leaf in the international drug control treaties, outlines the ECDD coca review process, and makes the human rights case for the removal of the plant from the treaty schedules.
Sharma and Sam-Agudu propose a framework to reassess coloniality in Global South public health, tackling harmful behaviours and systemic inequalities while developing new frameworks that elevate neglected knowledge systems.
Eschliman et al. show that stigmatising terminology in NIDA-funded grant abstracts has dropped by over half since 2013 and provide guidance for further elimination.
Zolopa et al. identify predictive factors of overdose requiring an emergency response at SIS in Montréal, including gender identity, age, housing status, and frequency and nature of use.
IDPC, HRI, and Youth RISE highlight how drug policies exacerbate poverty through exclusion from housing, social benefits, education, and employment, reinforcing stigma and discrimination.
HRW denounces human rights violations, including in relation to drug policy ranging from punitive laws to extrajudicial executions, and demands truth and justice.
